Download PDFPDF
Clinical features and risk factors of postsurgical gout
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Colchicine in postsurgical gout: practical implications
    • George Iype Varughese, Specialist registrar in Endocrinology & General Internal Medicine
    • Other Contributors:
      • Kashif Musarrat (Specialty Registrar and Dhanya Kalathil (Specialty Registrar) at Queen's Hospital, Burton-upon-Trent

    Dear Editor,

    We applaud Kang et al in their efforts to study the clinical features and risk factors of postsurgical gout [1]. They recommend prophylactic administration of colchicine prior to surgery to prevent postsurgical gout [1]. However, we should not forget that the dose of colchicine in the management of acute gout remains controversial [2-6], and caution should be exercised in deciding the prophylactic dose for s...

    Show More
    Conflict of Interest:
    None declared.